90 likes | 506 Views
Figure 1 PCSK9 binds the LDL receptor (LDLR), targeting it for degradation. Betteridge, D. J. (2013) PCSK9—an exciting target for reducing LDL-cholesterol levels Nat. Rev. Endocrinol. doi:10.1038/nrendo.2012.254.
E N D
Figure 1PCSK9 binds the LDL receptor (LDLR), targeting it for degradation Betteridge, D. J. (2013) PCSK9—an exciting target for reducing LDL-cholesterol levels Nat. Rev. Endocrinol.doi:10.1038/nrendo.2012.254